SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-004239
Filing Date
2021-09-13
Accepted
2021-09-13 09:06:08
Documents
2
Period of Report
2021-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannabics_8k.htm 8-K 14396
2 BOARD OF DIRECTOR'S RESOLUTION APPOINTING GABRIEL YARIV AS CHAIR cannabics_8k-ex1001.htm EX-10.1 5438
  Complete submission text file 0001683168-21-004239.txt   21279
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 211248770
SIC: 2834 Pharmaceutical Preparations